Stratatech, a Madison-based subsidiary of British-based Mallinckrodt Pharmaceuticals, has begun to test its StrataGraft skin tissue on children who have suffered serious burns, according to a report in the Wisconsin State Journal.
It marks the first time Statatech has studied its engineered skin tissue on pediatric burn patients.
